|
|
Prepublished online as a Blood First Edition Paper on September 19, 2002September 19, 2002; DOI 10.1182/blood-2001-12-0190.

Submitted December 10, 2001
Accepted September 6, 2002
Combined anti-coagulant and anti-selectin treatments prevent lethal intravascular coagulation
Keith E Norman*, Matthew J Cotter, James B Stewart, Kate B Abbitt, Majid Ali, Bart E Wagner, William A Wallace, S B Forlow, and Paul G Hellewell
Cardiovascular Research Group, Division of Clinical Sciences North, University of Sheffield, Sheffield, South Yorkshire, United Kingdom
Department of Histopathology, Northern General Hospital, Sheffield, South Yorkshire, United Kingdom
Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA
* Corresponding author; email: k.norman{at}shef.ac.uk.
Widespread microvascular injury followed by vessel obstruction may lead to disseminated intravascular coagulation. We describe a murine model wherein leukocytes interacting with inflamed microvessels in vivo are activated by antibodies. Treatment of TNF -primed mice with anti-Ly-6G antibodies reproduced many of the features of septic or traumatic shock including microvessel obstruction and coagulation, severe vasculitis, respiratory difficulties and vascular leakage. Mice lacking either E- or P-selectin were protected from this reaction as were animals treated with a combination of either selectin blocking antibodies and heparin or a selectin antagonist plus heparin. Combined blockade of leukocyte/platelet adhesion and coagulation may provide convincing protection in disseminated intravascular coagulation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. B. Abbitt, M. J. Cotter, V. C. Ridger, D. C. Crossman, P. G. Hellewell, and K. E. Norman
Antibody ligation of murine Ly-6G induces neutropenia, blood flow cessation, and death via complement-dependent and independent mechanisms
J. Leukoc. Biol.,
January 1, 2009;
85(1):
55 - 63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hutas, E. Bajnok, I. Gal, A. Finnegan, T. T. Glant, and K. Mikecz
CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis
Blood,
December 15, 2008;
112(13):
4999 - 5006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nechemia-Arbely, D. Barkan, G. Pizov, A. Shriki, S. Rose-John, E. Galun, and J. H. Axelrod
IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney Injury
J. Am. Soc. Nephrol.,
June 1, 2008;
19(6):
1106 - 1115.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Oostingh, M. Pozgajova, R. J. Ludwig, T. Krahn, W.-H. Boehncke, B. Nieswandt, and M. P. Schon
Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions
Haematologica,
April 1, 2007;
92(4):
502 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Di Giusto and G. C. King
Construction, Stability, and Activity of Multivalent Circular Anticoagulant Aptamers
J. Biol. Chem.,
November 5, 2004;
279(45):
46483 - 46489.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|